Source: Annual Congress 2006 - PG7 - Paediatric respiratory medicine: allergy for paediatric pulmonologists
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Dubois (Groningen, The Netherlands). Management of anaphylaxis. Annual Congress 2006 - PG7 - Paediatric respiratory medicine: allergy for paediatric pulmonologists

Member's Comments

No comment yet.

Related content which might interest you: Clinical effectiveness of anti-IgE therapy in severe asthma with fungus sensitization Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Ultra-rush sublingual immunotherapy: Safety of use for patients with various allergic manifestations Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Management of interleukin-2-induced severe bronchoconstriction Source: Eur Respir J 2007; 29: 612-613 Year: 2007 Unexpected severe systemic allergic reaction after hymenoptera sting in well controlled asthma during treatment with omalizumab Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Importance of concomitant local and systemic eosinophilia in uncontrolled asthma Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 Chronic oral corticosteroids use and persistent eosinophilia in severe asthma. The Belgian Severe Asthma Registry. Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020 Effect of oral corticosteroids on symptomatic reflux in severe allergic asthma: Is there a link? Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Clinical effectiveness of anti-IgE therapy in allergic severe asthma Source: International Congress 2014 – Asthma and COPD management Year: 2014 Immunogenicity of Mepolizumab in Patients with Severe Eosinophilic Asthma: Experience from the Clinical Development Program Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD Year: 2018 The ’real-life’ long-term efficacy of omalizumab in severe persistent IgE-mediated allergic asthma in Malta Source: International Congress 2016 – Asthma management Year: 2016 Management of severe and difficult-to-treat asthma Source: Annual Congress 2013 –Severe asthma: moving from phenotyping to endotyping Year: 2013 Safety and Efficacy of Omalizumab in Elderly Patients with Uncontrolled Allergic Asthma. Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 LATE-BREAKING ABSTRACT: A novel model of IgE-mediated passive pulmonary anaphylaxis in rats Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation Year: 2014 Study of Efficacy of Sublingual Immunotherapy in Cases Asthma & Allergic Rhinitis in India Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 Use of β-blockers and the risk of asthma exacerbations Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives Year: 2016 Severe asthmatic attack with cardiac arrest suspected to be induced by sulbactam sodium Source: International Congress 2014 – Clinical allergy Year: 2014 Food allergies, anaphylaxis and asthma Source: Annual Congress 2012 - PG6 Hot topics in paediatric allergy Year: 2012